Arthur Kaindl, Head of Varian, a Siemens Healthineers company, and Jakob Just-Bomholt, President and CEO of Elekta, shared on LinkedIn:
“Every patient deserves access to the best possible care. And every healthcare provider should have the flexibility to build the technology ecosystem that best supports that goal.
That is why interoperability matters. Across cancer care, providers increasingly operate complex environments that combine technologies from multiple partners.
Ensuring those systems can work together helps care teams access information more efficiently, streamline workflows, and focus on what matters most: delivering exceptional care to patients. Varian, the cancer-care business of Siemens Healthineers, and Elekta have a longstanding interoperability framework that supports many customers today.
We remain committed to that support and are now working to extend interoperability between Varian and Elekta technologies to modern I-HERO and SMRT standards.
The principle is simple: customers should have choice, and our industry has a responsibility to make that choice work for them.”
Quoting Jakob Just-Bomholt:
“Elekta and Siemens Healthineers to improve interoperability between platforms.
As cancer care becomes increasingly technology-driven, the systems supporting it need to work better together.
Healthcare providers make significant technology decisions based on their clinical and operational priorities. Interoperability can help ensure that those decisions continue to deliver value as cancer care evolves.
I’m pleased that Elekta and Siemens Healthineers have signed a letter of intent to work on standards-based interoperability between our oncology platforms. For Elekta, this is about supporting customers across diverse technology environments while continuing to advance the innovation that drives cancer care forward.
For me, this is part of our responsibility as technology providers: to keep advancing what is possible in cancer care while helping healthcare providers get more from the technologies they rely on today.
Ultimately, innovation creates value when it enables care teams to deliver the best possible care for the patients who depend on them”
You can also read: Exploring MRD-Informed Patient Management in Radiation Oncology – ASTRO
